natgillin/translations-raw huggingface dataset:
It is important that both tips make direct contact with the skin. 
Pomembno je, da se obe konici neposredno dotikata kože.
50 mg/ml For a full list of excipients, see section 6.1. 
50 mg/ml Za celoten seznam pomožnih snovi, glejte poglavje 6.1.
Within 5 minutes, the product dries on the skin. 
V 5 minutah se zdravilo na koži posuši.
Remove the plastic protective cover from the top of the glass vial. 
Odstranite plastičen zaščitni pokrovček z vrha steklene viale.
Thoroughly clean any contaminated clothing before reuse. 
Pred ponovno uporabo temeljito očistite vsa onesnažena oblačila.
For the attention of dog owner 
Opozorilo lastniku psa
ATCvet code: QN02AB03 
Oznaka ATC vet: QN02AB03
Your veterinarian received a separate information sheet (summary of product characteristics) with more details on the correct and safe administration of Recuvyra. 
Vaš veterinar je prejel posebne informacijske (Povzetek glavnih značilnosti zdravila) z več podrobnostmi o pravilnem in varnem dajanju Recuvyre.
Time to 1.0 ng/ml (hrs) 
Čas do 1,0 ng/ml (ure)
Shelf life after first broaching the vial: 30 days. 
Rok uporabnosti po prvem odpiranju viale: 30 dni.
The pharmacokinetic profile of the veterinary medicinal product is primarily characterised by the long period of systemic absorption. 
Za farmakokinetičen profil zdravila je predvsem značilno dolgo obdobje sistemske absorpcije.
This dog was treated on: Date 
Ta pes je bil zdravljen: Datum ura
Your veterinarian will ensure the product is stored correctly and safely for up to 3 years, but the contents of a bottle should be used within 30 days of the first dose being withdrawn. 
Veterinar bo zagotovil pravilno in varno shranjevanje zdravila do 3 leta, a po odvzemu prvega odmerka se mora vsebina stekleničke porabiti v 30 dneh.
Facilities for the maintenance of a patent airway, intermittent positive pressure ventilation (IPPV) and oxygen supplementation should be available. 
Na razpolago morajo biti naprave za vzdrževanje prehodnih dihalnih poti, intermitentno ventilacijo s pozitivnim tlakom (IPPV) in preskrbo s kisikom.
• Decreased stool production and some temporary weight loss. 
• Zmanjšano izločanje blata in začasno manjšo izgubo teže.
Pharmacotherapeutic group: Analgesic, opioid, phenylpiperidene derivative. 
Farmakoterapevtska skupina: analgetik, opioid, derivat fenilpiperidina.
Once seated, do not remove the adaptor. 
Ko adapter sedi, ga ne odstranjujte več.
Attaching the adaptor 
Pritrjevanje adapterja
The safety of the veterinary medicinal product in animals less than 6 months of age has not been established. 
Varnost zdravila ni ugotovljena pri živalih, starih manj od 6 mesecev.
The veterinary medicinal product should not be used in animals with systemic illness. 
Zdravilo se ne sme uporabljati pri živalih s sistemsko boleznijo.
Centre the adaptor directly over the top of the vial. 
Namestite adapter točno nad sredino vrha viale.
It is important that you do not allow any other dogs or pets you may have to lick or come into contact with the area between your dog's shoulder blades where your veterinarian has applied Recuvyra for at least 3 days (72 hours) following treatment, as this might cause adverse reactions in these animals. 
Pomembno je, da ne dovolite, da bi drugi psi ali domače živali, ki jih morda imate, lizali ali prihajali v stik z območjem med lopaticama vašega psa, kjer je veterinar nanesel Recuvyro, najmanj 3 dni (72 ur) po dajanju, ker lahko to povzroči neželene učinke pri teh živalih.
Rarely (i.e. in 0,01 to 0,1% of treated dogs) • Dysphoria and urinary retention. 
Redko (tj. od 0,01 do 0,1% zdravljenih psov • Disforija in zadrževanje urina.
Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu/. 
Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency, EMEA) http://www.ema.europa.eu/.
The ranges (90% interval) of pharmacokinetic parameters in dogs are given below: 
Območja farmakokinetičnih parametrov (90 %-ni intervali) pri psih so prikazana spodaj:
Recuvyra is supplied to your veterinarian in an amber glass bottle containing 10 ml of product. 
Recuvyra se dobavlja veterinarju v rjavi steklenički, ki vsebuje 10 ml izdelka.
If there is a risk of contact with the application site, suitable protective gloves must be worn. 
Če obstaja nevarnost stika z mestom dajanja, je treba nositi primerne zaščitne rokavice.
Each pack is supplied with one vial adaptor, 15 syringes and 15 applicator tips, as well as 15 package leaflets for animal owners, and 1 SPC (for the veterinarian). 
Vsako pakiranje vsebuje en adapterza viale, 15 brizg in 15 aplikacijskih nastavkov, 15 navodili za uporabo za lastnike živali in 1 Povzetkom glavnih značilnosti zdravila (za veterinarja).
If necessary, your veterinarian may administer treatment to your dog (for example a reversal agent called naloxone which has a very rapid effect within 1 - 2 minutes). 
Če je potrebno, lahko veterinar predpiše zdravljenje psa (npr. sredstvo za reverzijo, imenovano nalokson, ki ima zelo hiter učinek v 1-2 minutah).
As a precaution, RECUVYRA should not be administered by pregnant women. 
Iz previdnostnih razlogov naj Recuvyre ne dajejo nosečnice.
Tell your veterinarian if your dog is sick or was recently ill, if it has ever had breathing, heart or blood pressure problems or epilepsy, if it has ever had bowel or kidney problems or problems with its eyes, and what medicines your dog has taken, especially within the last month. 
Povejte veterinarju, če je pes bolan ali je bil pred kratkim bolan, če je kdaj imel težave z dihanjem, srcem in krvnim tlakom ali epilepsijo, če je kdaj imel težave s črevesjem ali ledvicami ali težave z očmi in katera zdravila je dobival, posebno v zadnjem mesecu.
• A polycarbonate Robertsite vial adaptor (allowing needleless luer connection to the vial). 
• Polikarbonaten adapter Robertsite za viale (ki omogoča brezigelni luer priključek na vialo)
Your dog will only be allowed to go home once it has recovered from its surgery, and is drinking and eating normally. 
Pes bo smel iti domov, ko si bo opomogel od kirurške operacije in bo normalno pil in jedel.
• Has broken, damaged or diseased skin at the treatment site. 
• Ima raztrgano, poškodovano ali bolno kožo na mestu zdravljenja.
Avoid contact with skin, as Recuvyra can be absorbed by human skin. 
Izogibajte se stiku s kožo, ker človeška koža lahko absorbira Recuvyro.
Dispose of waste material in accordance with local requirements 
Odlagajte odpadne snovi v skladu z lokalnimi predpisi.
Clear, colourless to light yellow solution. 
Bistra brezbarvna do svetlo rumena raztopina.
Sedation may persist beyond 24 hours after application. 
Sedacija lahko traja več kot 24 ur po dajanju.
Your veterinarian should not administer Recuvyra: 
Veterinar ne sme dajati Recuvyre:
To address the safety concerns remaining in relation to the novel type of product, and the uncertainty about possible interactions of concomitantly used products during the operation and in the postoperative period, the marketing authorisation holder should arrange for collation and assessment of detailed data on the clinical safety of the product in a representative sample of dogs. 
Za obravnavo preostalih varnostnih vprašanj, ki se nanašajo na novo vrsto zdravila in na negotovost glede možnih medsebojnih učinkov sočasno uporabljenih zdravil med operacijo in v obdobju po operaciji, mora imetnik dovoljenja za promet z zdravilom poskrbeti za zbiranje in oceno podrobnih rezultatov o klinični varnosti zdravila na reprezentativnem vzorcu psov.
At the moment of drying, approximately 2 to 5 minutes after application, fentanyl and octyl salicylate are absorbed into the stratum corneum. 
V trenutku osušitve, približno 2 do 5 minut po nanosu, se fentanil in oktilsalicilat absorbirata v stratum corneum.
However, for small children (15 kg) such contact might still result in serious exposure to fentanyl. 
Pri majhnih otrocih (15 kg) pa bi lahko imel takšen stik za posledico resno izpostavitev fentanilu.
• To your dog if it has already had a dose of Recuvyra within the last 7 days. 
• Če je pes v zadnjih 7 dneh že dobil odmerek Recuvyre.
The effects of the concomitant use of the veterinary medicinal product and α-adrenergic agonists have not been studied. 
Učinkov hkratne uporabe tega zdravila in α-adrenergičnih agonistov niso proučili.
The veterinary medicinal product has a narrow margin of safety and it is important to measure the dose accurately to avoid over-dosing. 
Zdravilo za uporabo v veterinarski medicini ima ozke varnostne meje in pomembno je, da se odmerek izmeri natančno in s tem prepreči preveliko odmerjanje.
Apply up to 0.5 ml onto the skin without moving the applicator tip. 
Nanesite do 0,5 ml na kožo, ne da bi prestavljali aplikacijski nastavek.
Do not use near a naked flame. 
Ne uporabljajte v bližini odprtega plamena.
Mild reductions in body temperature and heart and respiratory rates for up to 3 days following use are common. 
Pogosta so blaga znižanja telesne temperature in hitrosti bitja srca in dihanja do 3 dni po uporabi.
To help you remember when your dog was given Recuvyra by your veterinarian and how long you should not let children touch your dog in the place where the product was applied, your veterinarian will make a note in the spaces provided below. 
Da si boste lažje zapomnili, kdaj je veterinar dal Recuvyro vašemu psu in kako dolgo ne smete dovoliti otrokom, da se ga dotikajo na mestu, kjer je zdravilo nanešeno, bo veterinar naredil zabeležke na spodaj predvidenih mestih.
Very commonly (i.e. in more than 10% of treated dogs) 
Zelo pogosto (tj. pri več kot 10 % zdravljenih psov)
SMALL CHILDREN SHOULD NOT TOUCH THE DOG FOR 72 HOURS (3 days) AFTER RECUVYRA IS APPLIED TO THE DOG. 
MAJHNI OTROCI SE NE SMEJO DOTIKATI PSA 72 UR (3 dni) PO DAJANJU RECUVYRE PSU.
• Lowering of heart and breathing rates. 
• Znižanje hitrosti bitja srca in dihanja.
Banbury, Oxfordshire, OX16 4RS United Kingdom. 
Banbury, Oxfordshire, OX16 4RS Združeno Kraljestvo
Mild side effects such as sedation, may occur after a single accidental oral administration of more than 20 µg/kg of fentanyl (0.4 µl/kg Recuvyra). 
Blagi stranski učinki, kot je sedacija, se lahko pojavijo po enem nenamernem peroralnem zaužitju več kot 20 μg/kg fentanila (0,4 μl/kg Recuvyre).
The above side effects can occur up to 3 days (72 hours) after Recuvyra was given to your dog. 
Zgoraj navedeni stranski učinki lahko nastopajo do 3 dni (72) ur po dajanju Recuvyre psu.
de la Industria, 30 E-28108 Alcobendas (Madrid) Tel.: +34 91 663 5000 
de la Industria, 30 E-28108 Alcobendas (Madrid) Tel.: +34 91 663 5000 Spain
Higher oral doses may induce anaesthetic effects and cardiopulmonary depression. 
Večji oralni odmerki lahko povzročijo anestetične učinke in kardiopulmonalno depresijo.
The veterinary medicinal product is strictly limited for use in dogs. 
Uporaba zdravila je strogo omejena na pse.
• Except as a single dose at the recommended dose rate. 
• Drugače kot samo v enkratnem priporočenem odmerku.
Fentanyl plasma protein binding is estimated at approximately 60% in dogs. 
Ocenjujejo, da znaša pri psih vezanje fentanila na proteine v plazmi okoli 60 %.
Recuvyra should not be used if your dog is pregnant, lactating or is used for breeding, or if your dog is less than 6 months old. 
Recuvyra se ne sme uporabljati, če je vaša psica breja ali v obdobju laktacije, če se žival uporablja za vzrejo ali če je vaš pes star manj kot 6 mesecev.
• Mild sedation (sleepiness) for up to 24 hours after Recuvyra has been applied by your veterinarian. 
• Blago sedacijo (zaspanost) do 24 ur potem, ko je veterinar nanesel Recuvyro.
It is imperative that the veterinary medicinal product is not applied to any other site on the body than the dorsal scapular area, as absorption has been shown to vary between different locations of skin. 
Nujno je, da se to zdravilo ne nanese na nobeno drugo telesno mesto kot na hrbtno skapularno območje, ker je ugotovljeno, da se absorpcija spreminja med različnimi mesti na koži.
1 vial (10 ml) 1 vial adaptor 15 syringes 15 applicator tips 
1 viala (10 ml) 1 adapter za vialo 15 brizg
• Has an allergy to the active substance (fentanyl) or to any of the excipients. 
• Ima alergijo na zdravilno učinkovino (fentanil) ali katero od pomožnih snovi.
Fentanyl gradually moves through the skin into your dog's bloodstream and then relieves pain. 
Fentanil počasi potuje skozi kožo v krvni obtok psa in potem lajša bolečine.
Attaching adaptor (see Figure 1): 
Pritrjevanje adapterja (glejte sliko 1):
The duration of action of naloxone ranges between 45 minutes and 3 hours in the dog. 
Trajanje delovanja naloksona je za pse v območju med 45 minutami in 3 urami.
Gastrointestinal stasis can result in serious complications and consideration should be given to opiate reversal in case of excessive narcosis (see section 4.10). 
Gastrointestinalni zastoj ima lahko za posledico resne komplikacije in razmisliti je treba o prekinitvi dajanja opiatov, če je narkoza premočna (glejte poglavje 4.10).
When using Recuvyra your veterinarian should use less anaesthetic agents and administer them only to achieve the desired effect. 
Pri uporabi Recuvyre mora veterinar uporabljati manj anestetikov in jih dajati samo za doseganje želenih učinkov.
Fentanyl very commonly causes dose-dependent sedation in dogs which is associated with potential decreased food and water intake, decreased stool production and transient weight loss. 
Odvisno od odmerka fentanil zelo pogosto povzroča sedacijo psov, ki je združena z možnim zmanjšanjem zauživanja hrane in vode, zmanjšanjem izločanja blata in prehodno izgubo teže.
In field trials, 2 % of dogs treated with the veterinary medicinal product required reversal of adverse opiate effects with naloxone. 
Pri preskušanju na terenu je 2 % psov, zdravljenih s tem zdravilom, potrebovalo reverzijo neželenih opiatnih učinkov z naloksonom.
Therefore, α2-adrenergic agonists should be used with caution in animals dosed with the veterinary medicinal product due to potentially additive or synergistic effects. 
Zato je treba α2adrenergične agoniste uporabljati previdno pri živalih, ki so prejele to zdravilo zaradi možnih aditivnih ali sinergističnih učinkov.
This depression may be reversed by use of a suitable reversal agent, such as naloxone. 
To depresijo je mogoče preprečiti z uporabo primernega sredstva za reverzijo, kot je nalokson.
In case of accidental exposure of protective clothing to the veterinary medicinal product, immediately remove any contaminated clothing. 
Ob nenamerni izpostavitvi zaščitne obleke zdravilu takoj odstranite vso onesnaženo obleko.
Store the Summary of Product Characteristics together with the vial, and read before use 
Hranite Povzetek glavnih značilnosti zdravila skupaj z vialo in ga preberite pred uporabo.
Vomiting and diarrhoea are also common adverse reactions. 
Bruhanje in driska sta tudi običajna neželena učinka.
The effects of transdermal fentanyl could last longer than the effects of the opioid reversal agent. 
Učinki transdermalnega fentanila lahko trajajo dlje kot učinki sredstva za reverzijo opioidov.
Fentanyl exerts its analgesic action by binding to and activating µ (mu) opioid receptors that are predominantly found in the pain regulating areas of the brain and spinal cord. 
Fentanil deluje analgetsko z vezanjem na in aktiviranjem μ (mi) opioidnih receptorjev, ki se pretežno nahajajo v območjih možganov in hrbtenjače, ki regulirajo bolečino.
• To anywhere except between your dogs shoulder blades. 
• Drugam kakor samo med lopatice.
The clearance of fentanyl ranges from 1.7 to 4.7 l/h/kg in dogs. 
Izčistek fentanila je v območju od 1,7 do 4,7 l/h/kg pri psih.
Do not allow other animals contact with the application site for at least 72 hours after application. 
Ne dovolite, da pridejo druge živali v stik z mestom dajanja najmanj 72 ur po dajanju.
If a small child touches the application site within 72 hours of application, the child's skin that touched the dog (for example, fingers) should not contact the child's mouth, and the skin should be washed with soap and water. 
Če se majhen otrok dotika mesta nanosa do 72 ur po aplikaciji, se njegova koža, ki je bila v stiku s psom (npr. prsti), ne sme dotakniti otrokovih ust, kožo pa je treba oprati z milom in vodo.
Do not store or use near a naked flame. 
Ne shranjujte ali uporabljajte v bližini odprtega ognja.
Do not use the veterinary medicinal product in lactating or pregnant bitches or breeding animals (see section 4.7). 
Ne uporabite zdravila pri psicah med laktacijo ali brejostjo ali za vzrejne živali (glejte poglavje 4.7).
Fentanyl partitions from the stratum corneum through the deeper skin layers and into the systemic circulation over a period of days. 
Fentanil se porazdeljuje iz stratum corneum skozi globlje kožne plasti in v sistemski obtok več dni.
Therefore, special precautions should be taken by people whose dogs have been treated with Recuvyra. 
Zato morajo ljudje, katerih psi so bili zdravljeni z Recuvyro, izvajati posebne ukrepe.
However, for children such contact might still result in serious exposure to fentanyl. 
Za otroke pa bi takšen stik še lahko imel za posledico resno izpostavitev fentanilu.
Once Recuvyra has been administered, your veterinarian will carefully monitor your dog to ensure it responds safely to the product. 
Po dajanju Recuvyre bo veterinar skrbno nadziral psa, da bo zagotovil njegov varen odziv na zdravilo.
Before using the product it is recommended to consider the availability of an opiate antagonist, e.g. naloxone, in case reversal is required (see sections 4.6 and 4.10). 
Pred uporabo zdravila je priporočljivo imeti pri roki opiatni antagonist, npr. nalokson, če je potrebna reverzija (glejte poglavji 4.6 in 4.10).
DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED Detailed information on this product is available on the website of the European Medicines Agency (EMA) http://www.ema.europa.eu/. 
DATUM ZADNJE ODOBRITVE NAVODIL ZA UPORABO Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency, EMEA) http://www.ema.europa.eu/.
Do not allow the dog or other animals to lick the site of application as oral bioavailability following licking is high in the first five minutes after application. 
Ne dovolite, da pes ali druge živali ližejo mesto dajanja, ker je peroralna biološka razpoložljivost, ki sledi lizanju, prvih 5 minut po dajanju velika.
Do not use in case of hypersensitivity to the active substance or to any of the excipients. 
Ne uporabite v primeru preobčutljivosti na zdravilno učinkovino ali katero od pomožnih snovi.
Additional class effects that may be observed following administration of fentanyl include dysphoria and urinary retention, therefore appropriate precautionary measures should be in place. 
Dodatni učinki te skupine, ki se lahko pojavijo po dajanju zdravila Fentanil, vključujejo disforijo in zastajanje urina, zato se je treba držati ustreznih previdnostnih ukrepov.
Appropriate eye lubrication should therefore be applied prior to and following surgery and continued until the dog resumes normal blinking function. 
Zato je treba pred in po kirurški operaciji nanesti primerno mazilo za oči in nadaljevati z dajanjem, dokler pes ne začne normalno mežikati.
Also, the veterinary medicinal product might cause skin irritation. 
Zdravilo tudi lahko povzroči iritacijo kože.
Children should not touch the dog before: Date 
Otroci se lahko dotikajo psa od: Datum ura
The veterinary medicinal product should be used with caution in conjunction with morphine or other opioid type analgesics as the effects have not been studied. 
To zdravilo je treba uporabljati previdno v povezavi z morfinom ali drugimi analgetiki opioidnega tipa, ker učinkov niso bili proučeni.
Recuvyra also contains octyl salicylate and isopropyl alcohol. 
Recuvyra vsebuje tudi oktilsalicilat in izopropil alkohol.
The most common symptoms associated with fentanyl overdose in people include respiratory depression, sedation and myosis. 
Najbolj pogosti simptomi pri prevelikem odmerjanju fentanila pri ljudeh so depresija dihanja, sedacija in zoženje zenic.
As a class, opioids, including this veterinary medicinal product, may cause low body temperature, slow respiratory rate, low blood pressure or slow heart rate. 
Opioidi kot skupina, v katero spada to zdravilo, lahko povzročijo nizko telesno temperaturo, počasno dihanje, nizek krvni tlak ali počasen srčni utrip.
The recommended dose is 2.6 mg fentanyl/kg bodyweight (i.e. 0.052 ml/kg bw), applied topically to the dorsal scapular area 2 to 4 hours prior to surgery and according to the dosing table below. 
Priporočeni odmerek je 2,6 mg fentanila/kg telesne teže (tj. 0,052 ml/kg telesne teže), ki se nanese topikalno na hrbtno skapularno območje 2 do 3 ure pred kirurško operacijo v skladu s spodnjo tabelo odmerkov.
Do not use in dogs with cardiac failure, hypotension, hypovolaemia, respiratory depression, hypertension, a history of epilepsy, non age related corneal pathology or those who have or are suspected of having a paralytic ileus. 
Ne uporabite pri psih s srčno napako, hipotenzijo, hipovolemijo, depresijo dihanja, hipertenzijo, epilepsijo v preteklosti in kornealno patologijo, ki ni v zvezi s staranjem, ali pri tistih, ki imajo ali za katere obstaja sum o paralitičnem ileusu.
• Vomiting and diarrhoea. 
• Bruhanje in drisko.
Administration of naloxone at 0.04 mg/kg may be used to reverse adverse reactions associated with topical fentanyl. 
Dajanje naloksona v odmerkih 0,04 mg/kg se lahko uporablja za reverzijo neželenih učinkov, povezanih s topikalnim fentanilom.
Two to four hours before your dog has surgery, the recommended dose (2.6 mg fentanyl/kg bodyweight) of Recuvyra solution is applied directly on the skin between the dog's shoulder blades. 
Dve do štiri ure pred kirurško operacijo se psu nanese priporočeni odmerek (2,6 mg fentanila/kg telesne teže) raztopine Recuvyre neposredno na kožo med lopaticama.
1.3 - Not Reached 
1,3-ni dosežen
After the application site is dry, direct contact to the application site should not pose a risk to adults. 
Ko je mesto nanosa suho, naj bi direkten stik z mestom ne predstavljal nevarnosti za odrasle.
Severe overdose may result in renal failure secondary to hypotension produced by gastrointestinal hypomobility. 
Močno preveliko odmerjanje ima lahko za posledico odpoved ledvic, ki sledi hipotenziji, povzročeni z gastrointestinalno hipomobilnostjo.
Do not blow out any residual volume in the syringe or applicator tip as this has been accounted for in the dosing table. 
Ne izpihujte preostale tekočine iz brizge ali aplikacijskega nastavka, ker je ta všteta v tabeli odmerkov.
The veterinary medicinal product should not come into direct contact with the oral cavity or mucous membranes of dogs. 
Zdravilo za uporabo v veterinarski medicini ne sme priti v neposreden stik z ustno votlino ali sluznico psov.
Recuvyra is a solution designed to be applied to the skin between the shoulder blades of your dog (see picture) only by a veterinarian using a specially designed single use applicator, which does not involve any needles. 
Recuvyra je raztopina, zasnovana za nanašanje na kožo med lopaticama vašega psa (glejte sliko), ki ga opravi samo veterinar s pomočjo posebej zasnovanega aplikatorja za enkratno uporabo, ki ne potrebuje igel.
Only use the syringes provided. 
Uporabljajte samo priložene brizge.
WITHDRAWAL PERIOD Not applicable. 
Aplikacijski nastavek ni za ponovno uporabo.
A single dose relieves pain for at least 4 days. 
En odmerek lajša bolečine najmanj 4 dni.
You should tell your veterinarian if you know any of these applies about your dog before treatment is given. 
Če veste, da karkoli od tega velja za vašega psa, povejte vašemu veterinarju pred začetkom zdravljenja.
As Recuvyra contains fentanyl (the active substance), it will only ever be kept in a veterinarian's surgery under secure conditions. 
POSEBNA NAVODILA ZA SHRANJEVANJE Ker Recuvyra vsebuje fentanil (zdravilno učinkovino), se shranjuje samo v veterinarskem kirurškem oddelku v varnih pogojih.